Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,811 | -31,154 | -26,388 | -6,845 | -86,161 |
| Depreciation Amortization | 96 | 77 | N/A | N/A | 673 |
| Accounts receivable | N/A | N/A | 7 | 39 | N/A |
| Accounts payable and accrued liabilities | 558 | 917 | -128 | 87 | -3,450 |
| Other Working Capital | -6,281 | 5,506 | -1,106 | 100 | -868 |
| Other Operating Activity | 12,931 | 2,337 | 10,007 | 3,477 | 10,881 |
| Operating Cash Flow | $-25,507 | $-22,317 | $-17,608 | $-3,142 | $-78,925 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -380,054 | -21,881 | 15,366 | N/A | -8,693 |
| PPE Investments | -22 | -125 | 695 | N/A | -144 |
| Net Acquisitions | N/A | N/A | 5,849 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 83 | 0 | 0 |
| Investing Cash Flow | $-380,076 | $-22,006 | $21,993 | $N/A | $-8,837 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 8,500 | 3,300 | 0 |
| Debt Repayment | N/A | N/A | N/A | N/A | -9,492 |
| Common Stock Issued | 314,335 | 173,805 | 5,954 | 0 | 94,788 |
| Financing Cash Flow | $314,335 | $173,805 | $14,454 | $3,300 | $85,296 |
| Beginning Cash Position | 148,627 | 19,145 | 306 | 148 | 48,490 |
| End Cash Position | 57,379 | 148,627 | 19,145 | 306 | 46,024 |
| Net Cash Flow | $-91,248 | $129,482 | $18,839 | $158 | $-2,466 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,507 | -22,317 | -17,608 | -3,142 | -78,925 |
| Capital Expenditure | -22 | -125 | -3 | N/A | -144 |
| Free Cash Flow | -25,529 | -22,442 | -17,611 | -3,142 | -79,069 |